Canada markets open in 6 hours 17 minutes

Apyx Medical Corporation (APYX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3200+0.0600 (+4.76%)
At close: 04:00PM EDT
1.3000 -0.02 (-1.52%)
After hours: 04:06PM EDT

Apyx Medical Corporation

5115 Ulmerton Road
Clearwater, FL 33760-4004
United States
727 384 2323

IndustryMedical Devices
Full Time Employees252

Key Executives

NameTitlePayExercisedYear Born
Mr. Charles D. Goodwin IIPresident, CEO & Director813.13kN/A1967
Mr. Matthew C. Hill CPACFO, Treasurer & Secretary445.95kN/A1969
Mr. Moshe CitronowiczSenior Vice President405.47kN/A1953
Mr. Todd HornsbyExecutive Vice President561.77kN/A1977
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Corporate Governance

Apyx Medical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.